Column Group L P - Insider Trading & Ownership

Entity
Company
Location
1700 Owens Street, Suite 500, San Francisco, CA
Summary
The estimated value of insider holdings of Column Group L P is at least $14.4M dollars as of April 8, 2024. Column Group L P is the 10%+ Owner of Nurix Therapeutics, Inc. and owns shares of Nurix Therapeutics, Inc. (NRIX) stock worth about $14.4M. Column Group L P is the Director, 10%+ Owner of NGM BIOPHARMACEUTICALS INC and owns shares of NGM BIOPHARMACEUTICALS INC stock worth about $1.34K.
All Insider Reports
All Insider Reports

Ownership of Column Group L P

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NRIX Nurix Therapeutics, Inc. 10%+ Owner $14.4M May 7, 2021
NGM NGM BIOPHARMACEUTICALS INC Director, 10%+ Owner $1.34K Apr 5, 2024

Insider Transactions Reported by Column Group L P:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.